FibroGen, Inc.
NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-assocaited conditions by increasing endogenous erythropoietin in vitro and in vivo.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
4 Mar 2021